Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126713521 | 12671352 | 1 | I | 20160609 | 20160609 | 20160822 | 20160822 | PER | US-TEVA-669614USA | TEVA | 63.50 | YR | F | Y | 87.98000 | KG | 20160822 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126713521 | 12671352 | 1 | PS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Oral | 360 MILLIGRAM DAILY; | UNKNOWN | 76191 | 360 | MG | TABLET | QD | |||||
126713521 | 12671352 | 2 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
126713521 | 12671352 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126713521 | 12671352 | 1 | Hypersensitivity |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126713521 | 12671352 | Extra dose administered |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126713521 | 12671352 | 1 | 20160609 | 20160609 | 0 | |
126713521 | 12671352 | 2 | 2006 | 0 | ||
126713521 | 12671352 | 3 | 2006 | 0 |